FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3103460883> ?p ?o ?g. }

• W3103460883 endingPage "401" @default.
• W3103460883 startingPage "392" @default.
• W3103460883 abstract "In patients at risk of cancer therapy-related cardiac dysfunction (CTRCD), initiation of cardioprotective therapy (CPT) is constrained by the low sensitivity of ejection fraction (EF) for minor changes in left ventricular (LV) function. Global longitudinal strain (GLS) is a robust and sensitive marker of LV dysfunction, but existing observational data have been insufficient to support a routine GLS-guided strategy for CPT. This study sought to identify whether GLS-guided CPT prevents reduction in LVEF and development of CTRCD in high-risk patients undergoing potentially cardiotoxic chemotherapy, compared with usual care. In this international, multicenter, prospective, randomized controlled trial, 331 anthracycline-treated patients with another heart failure risk factor were randomly allocated to CPT initiation guided by either ≥12% relative reduction in GLS (n = 166) or >10% absolute reduction of LVEF (n = 165). Patients were followed for EF and development of CTRCD (symptomatic EF reduction of >5% or >10% asymptomatic to <55%) over 1 year. Of 331 randomized patients, 2 died, and 22 withdrew consent or were lost to follow-up. Among 307 patients (age: 54 ± 12 years; 94% women; baseline LVEF: 59 ± 6%; GLS: –20.6 ± 2.4%) with a median (interquartile range) follow-up of 1.02 years (0.98 to 1.07 years), most (n = 278) had breast cancer. Heart failure risk factors were prevalent: 29% had hypertension, and 13% had diabetes mellitus. At the 1-year follow-up, although the primary outcome of change in LVEF was not significantly different between the 2 arms, there was significantly greater use of CPT, and fewer patients met CTRCD criteria in the GLS-guided than the EF-guided arm (5.8% vs. 13.7%; p = 0.02), and the 1-year EF was 57 ± 6% versus 55 ± 7% (p = 0.05). Patients who received CPT in the EF-guided arm had a larger reduction in LVEF at follow-up than in the GLS-guided arm (9.1 ± 10.9% vs. 2.9 ± 7.4%; p = 0.03). Although the change in LVEF was not different between the 2 arms as a whole, when patients who received CPT were compared, those in the GLS-guided arm had a significantly lower reduction in LVEF at 1 year follow-up. Furthermore, GLS-guided CPT significantly reduced a meaningful fall of LVEF to the abnormal range . The results support the use of GLS in surveillance for CTRCD. (Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes [SUCCOUR]; ACTRN12614000341628 )" @default.
• W3103460883 created "2020-11-23" @default.
• W3103460883 creator A5019668481 @default.
• W3103460883 creator A5032272271 @default.
• W3103460883 creator A5034413859 @default.
• W3103460883 creator A5036077848 @default.
• W3103460883 creator A5047837445 @default.
• W3103460883 creator A5051942853 @default.
• W3103460883 creator A5052989862 @default.
• W3103460883 creator A5059756974 @default.
• W3103460883 creator A5073163158 @default.
• W3103460883 creator A5074267679 @default.
• W3103460883 creator A5075396473 @default.
• W3103460883 creator A5077892878 @default.
• W3103460883 date "2021-02-01" @default.
• W3103460883 modified "2023-10-12" @default.
• W3103460883 title "Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy" @default.
• W3103460883 cites W148860973 @default.
• W3103460883 cites W1492360552 @default.
• W3103460883 cites W1968148627 @default.
• W3103460883 cites W2029542561 @default.
• W3103460883 cites W2143967622 @default.
• W3103460883 cites W2147646179 @default.
• W3103460883 cites W2154066911 @default.
• W3103460883 cites W2170278431 @default.
• W3103460883 cites W2260466831 @default.
• W3103460883 cites W2530921721 @default.
• W3103460883 cites W2531494032 @default.
• W3103460883 cites W2574931198 @default.
• W3103460883 cites W2803622815 @default.
• W3103460883 cites W2808262624 @default.
• W3103460883 cites W2964279907 @default.
• W3103460883 cites W2969461497 @default.
• W3103460883 cites W2999122927 @default.
• W3103460883 cites W3008757291 @default.
• W3103460883 doi "https://doi.org/10.1016/j.jacc.2020.11.020" @default.
• W3103460883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34082918" @default.
• W3103460883 hasPublicationYear "2021" @default.
• W3103460883 type Work @default.
• W3103460883 sameAs 3103460883 @default.
• W3103460883 citedByCount "194" @default.
• W3103460883 countsByYear W31034608832020 @default.
• W3103460883 countsByYear W31034608832021 @default.
• W3103460883 countsByYear W31034608832022 @default.
• W3103460883 countsByYear W31034608832023 @default.
• W3103460883 crossrefType "journal-article" @default.
• W3103460883 hasAuthorship W3103460883A5019668481 @default.
• W3103460883 hasAuthorship W3103460883A5032272271 @default.
• W3103460883 hasAuthorship W3103460883A5034413859 @default.
• W3103460883 hasAuthorship W3103460883A5036077848 @default.
• W3103460883 hasAuthorship W3103460883A5047837445 @default.
• W3103460883 hasAuthorship W3103460883A5051942853 @default.
• W3103460883 hasAuthorship W3103460883A5052989862 @default.
• W3103460883 hasAuthorship W3103460883A5059756974 @default.
• W3103460883 hasAuthorship W3103460883A5073163158 @default.
• W3103460883 hasAuthorship W3103460883A5074267679 @default.
• W3103460883 hasAuthorship W3103460883A5075396473 @default.
• W3103460883 hasAuthorship W3103460883A5077892878 @default.
• W3103460883 hasBestOaLocation W31034608831 @default.
• W3103460883 hasConcept C121608353 @default.
• W3103460883 hasConcept C126322002 @default.
• W3103460883 hasConcept C177713679 @default.
• W3103460883 hasConcept C2778022156 @default.
• W3103460883 hasConcept C2983331546 @default.
• W3103460883 hasConcept C71924100 @default.
• W3103460883 hasConceptScore W3103460883C121608353 @default.
• W3103460883 hasConceptScore W3103460883C126322002 @default.
• W3103460883 hasConceptScore W3103460883C177713679 @default.
• W3103460883 hasConceptScore W3103460883C2778022156 @default.
• W3103460883 hasConceptScore W3103460883C2983331546 @default.
• W3103460883 hasConceptScore W3103460883C71924100 @default.
• W3103460883 hasFunder F4320320442 @default.
• W3103460883 hasFunder F4320334506 @default.
• W3103460883 hasFunder F4320334705 @default.
• W3103460883 hasIssue "4" @default.
• W3103460883 hasLocation W31034608831 @default.
• W3103460883 hasOpenAccess W3103460883 @default.
• W3103460883 hasPrimaryLocation W31034608831 @default.
• W3103460883 hasRelatedWork W2029679708 @default.
• W3103460883 hasRelatedWork W2365364931 @default.
• W3103460883 hasRelatedWork W2418638721 @default.
• W3103460883 hasRelatedWork W2773353201 @default.
• W3103460883 hasRelatedWork W2804884407 @default.
• W3103460883 hasRelatedWork W2985265442 @default.
• W3103460883 hasRelatedWork W3107519578 @default.
• W3103460883 hasRelatedWork W4252371801 @default.
• W3103460883 hasRelatedWork W4285386966 @default.
• W3103460883 hasRelatedWork W4306151923 @default.
• W3103460883 hasVolume "77" @default.
• W3103460883 isParatext "false" @default.
• W3103460883 isRetracted "false" @default.
• W3103460883 magId "3103460883" @default.
• W3103460883 workType "article" @default.